| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8669280 | The Journal of Heart and Lung Transplantation | 2018 | 7 Pages |
Abstract
The incorporation of an anti-A/B immunoadsorption column into the extracorporeal circuit reduces allogeneic blood product requirement for ABO-incompatible heart transplantation, while providing efficacious removal of anti-A and anti-B isohemagglutinins. This can be undertaken within the time period of CPB before graft reperfusion and expands the potential recipient pool to larger patients with higher isohemagglutinin titers.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Alex LCCP, Richard LCCP, Richard LCCP, Kenth PhD, Ayad PhD, Victor MD, Michael MD,